Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
暂无分享,去创建一个
[1] P. R. Weeren,et al. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis. , 2010, Equine veterinary journal.
[2] M. Runge,et al. Age-related changes in matrix metalloproteinase-9 regulation in cultured mouse aortic smooth muscle cells , 2004, Experimental Gerontology.
[3] E. Sadoun,et al. Inhibited angiogenesis in aging: a role for TIMP-2. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[4] F. Cambien,et al. Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease , 2003, Circulation.
[5] K. Fujimoto,et al. Increased serum matrix metalloproteinase-1 concentration predicts advanced left ventricular remodeling in patients with acute myocardial infarction. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[6] F. Dunn,et al. TIMP-1: A Marker of Left Ventricular Diastolic Dysfunction and Fibrosis in Hypertension , 2002, Hypertension.
[7] L. Matrisian,et al. Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.
[8] A. Feldman,et al. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. , 2000, Cardiovascular research.
[9] Q. Sang,et al. Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.
[10] T. Ueno,et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. , 1998, Journal of the American College of Cardiology.
[11] S. Shroff,et al. Fibrillar Collagen and Myocardial Stiffness in the Intact Hypertrophied Rat Left Ventricle , 1989, Circulation research.